Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Mobile-based telemedicine to improve quality of life for chronic heart failure patients

Official title: Effectiveness of Mobile-Based Telemedicine on Health-Related Quality of Life Among Patients With Chronic Heart Failure: Protocol for a Quasi-Experimental Study

Run by Select College · NCT07650474 · Data updated 2026-11-12

We’re testing whether a mobile phone–based program that sends reminders, education, and follow-up can improve quality of life for adults with chronic heart failure in Ethiopia.

More Chronic Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment72 (estimated)
SponsorSelect College
Academic / other
Locations1 site (Addis Ababa)
StatusRecruiting
StartedMarch 2, 2026
Main results expectedJuly 1, 2026
Study endsAugust 21, 2026
Registry record updatedJune 17, 2026
Trial IDNCT07650474 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with NYHA class II–III heart failure, LVEF ≤40%, access to a mobile phone, and ability to communicate in Amharic, Oromic, or English.

Probably not a fit

Individuals with NYHA class IV, severe comorbidities, cognitive or psychiatric impairments, or those already in another telemedicine study may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares routine care alone to routine care plus an 8-week mobile-based telemedicine program for adults with chronic heart failure. The program includes scheduled calls, text messages, and WhatsApp communications for education, self-care guidance, medication adherence, and lifestyle advice. Quality of life is measured before and after the intervention using the Minnesota Living with Heart Failure Questionnaire. The study uses a quasi-experimental design with a nonrandomized control group, enrolling 70 participants at Menelik II Comprehensive Specialized Hospital in Addis Ababa.

Why it matters

Potential benefit: If successful, participants may experience improvements in daily functioning and overall well-being due to better symptom management and adherence.

How similar studies have gone: Previous studies in telemedicine have shown mixed results; this study explores feasibility and effectiveness in a resource-limited setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-65 years who will be diagnosed with CHF (NYHA class II⁃III)
* Patients with reduced left ventricular ejection fraction LVEF ≤ 40%
* Patient who will have access to a mobile phone and will be able to use it
* Patients who will be able to communicate in Amharic, Oromic, or English
* Patients who will provide written informed consent
* Patients who will be diagnosed with HF lasting ≥ 6 months, to be confirmed by echocardiography and clinical assessment
* Patients with no contraindications for mild to moderate physical activity

Exclusion Criteria:

* Patients with NYHA class IV or who will require intensive care at enrollment
* Patients with other severe medical conditions (e.g., end-stage renal disease, \& end stage liver disease)
* Patients with severe cognitive impairment or psychiatric illness that will interfere with participation
* Patients already enrolled in another telemedicine or intervention study
* Pregnant and lactating women

Where it's running

  • Menelik II Comprehensive Specialized Hospital
    Addis Ababa, Ethiopia
    Recruiting

Study contacts

  • Principal investigator: Gudisa Bereda — Marie Stopes International Ethiopia, Ambo, Ethiopia
  • Study coordinator: Gudisa Bereda, B.Pharm, MPH cand
  • Email: gudisabareda95@gmail.com
  • Phone: +251-913118492

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.